MASSACHUSETTS FINANCIAL SERVICES CO /MA/

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 912938 Boston, MA

Position in ACAD

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$22,701,282

-$5,944,738 QoQ

Shares Held

1,019,824

-4.9% QoQ

Ownership

0.596%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 99.03336261943238.ToString("F0")% Shared 0.9666373805676273.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $1,374,765,738 across 53 Biotechnology names. ACAD ranks #10 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	1,860,669	$425,590,816
2	TECH	BIO-TECHNE Corp	3,733,248	$195,099,537
3	ALNY	Alnylam Pharmaceuticals, Inc.	496,004	$164,112,841
4	VRTX	Vertex Pharmaceuticals Inc / Ma	327,498	$146,240,953
5	LGND	Ligand Pharmaceuticals Inc	411,543	$82,164,559
6	BNTX	BioNTech SE	670,514	$59,595,283
7	IONS	Ionis Pharmaceuticals Inc	666,116	$50,018,650
8	INCY	Incyte Corp	410,729	$38,657,809

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$22,701,282	1,019,824	-4.9%	Shares	Defined	2026-05-14
2025-12-31	$28,646,020	1,072,483	-3.4%	Shares	Sole	2026-01-22
2025-09-30	$23,702,892	1,110,726	+1792.6%	Shares	Sole	2025-10-29
2025-06-30	$1,265,900	58,688	+1.3%	Shares	Sole	2025-08-08
2025-03-31	$962,765	57,963	-2.2%	Shares	Sole	2025-05-02
2024-12-31	$1,087,843	59,283	-2.9%	Shares	Sole	2025-02-12
2024-09-30	$938,964	61,051	-2.4%	Shares	Sole	2024-11-12
2024-06-30	$1,016,112	62,530	+3.5%	Shares	Sole	2024-08-09
2024-03-31	$1,117,350	60,430	-0.2%	Shares	Sole	2024-05-14
2023-12-31	$1,896,258	60,564	—	Shares	Sole	2024-02-08
No filing history on record for this holder in this stock.